The Respert Rundown - Tuesday Edition Nothing makes me

New Post Public Reply Private Reply Replies (1) Message Board
Respert24
1,156
The Respert Rundown - Tuesday Edition

Nothing makes me happier than a PR. As a shareholder since January of 2019 I've been conditioned like Pavlov's dog to look for a 6am EST press release because that's when they'd usually hit. Once or twice I looked at 6 only to be disappointed before hearing a ding at 6:01 for an email coming in a minute later than normal.

Seriously. I got it bad.

I'm awake well before 6am almost every single day because of Cytodyn. I don't want to wake up at 5am or 4:27am, but it happens anyways.

Pavlov.

Back to Pavlov, I always assumed it was one dog he used and googled it looking for his/her name. After all, we never hear of the dog's name, just that it was Pavlov's. That ain't cool. I know from watching Yakov Smirnoff that in Russia, you don't name dogs. Dogs name you. But it turns out that his dog did have a name. Just like the other 39 dogs he used in experiments had a name. I didn't realize he was using more than one dog and for some reason I'm mildly annoyed. And for some reason I refreshed my email just now in case there was a PR.

There wasn't.

Anyways, we got a shiny new PR yesterday near bedtime here on the east coast. What the hell is that all about? Timing for the opening bell in the Philippines? The only time our PR team is awake? Hell, if the PR person is anything like me they set that email to "post" hours after they'd already left to play golf on company time. NP was sitting in his office nodding his head that his PR team was on their game while at that exact moment his PR person was accidentally skulling a wedge 30 yards over the green. I know of this technique because I employed it today. I shot an 88, which is a "bad" round for me when I'm playing well but was actually pretty good today considering I went something like 15 holes before I hit a green from far enough away to necessitate using a repair tool. Anywho...

The PR didn't move the needle today but that's both expected and OK. It wasn't a definitive announcement of anything, which doesn't bother me at all because I like to be informed of the goings on. But you'd think Cytodyn is obligated to only drop earth-shattering PRs the way a lot of message board & Seeking Alpha folks think. It seems NP is learning on the fly to be more careful about how much he shares and how often he does it. I like it.

Speaking of careful, I was NOT careful tonight with how much seasoning and butter I used on my two filet mignons. Don't get me wrong, they were delicious. But if you could wring my mouth out I feel like you'd get at least 3 tablespoons of butter and the salinity of said butter would support floating without effort. But hey, thems the breaks when you're eating for that 20 extra yards off the tee AMIRIGHTCYTODYNSPRPERSON?

Sorry, I think I just got either a PR (protein rush) or a BP (butter poisoning). Either way, please don't forget that I bring you the absolute best in technical analysis. We're in a classic buy-sell right now and don't let anyone tell you otherwise.

Onwards.

Many people thought that Savage guy was going to get a Leronlimab mention on during his interview with Trump today. Didn't happen. Unless you began following CYDY within the last few months you'll likely have already come to terms with how little the world currently cares to know about Leronlimab. (so far) And that's OK for the moment. If CD12 shows impressive results and we still don't have anyone talking about us then I'll be happy to declare a state of Shenanigans. But I don't think that would occur. Who wouldn't report on the first drug trial that unequivocally showed it can lower the death toll from Covid?

Also, if I'm forced to declare a state of Shenanigans I'm not sure there's enough mozzarella sticks and stupid shit for the walls to go around. Shout out to my fellow Super Troopers fans. #RattlesnakeKnowsWhatI'mTalkingAbout

There's still a few posters on every board that just can't figure out how to use that darn BING function on their Netscape to figure out the basics of Leronlimab trials. "Hey guys, I haven't been able to figure this out and maybe you all can help but is Leronlimab being tested in severe or critical patients, or just with milder people? Do they just throw it at them from a few feet away or is there a way that it gets into their bodies more effectively? If you get hit in the face with a Leronlimab will you die from Covid or are you protected? My mom is sick and I told her she needs a Leronlimab but I don't know who to ask does anyone know who can slap a Leronlimab into my sick mom?

On another important subject. Yes, other drugs are going to show some level of effect in Covid and they may or may not beat us to market. Before you get all butt-hurt about how we may not be first and start ragging on NP please consider that every drug that claims to have a cure also is on record stating they can't produce enough product for the entire world. We're actually in a good position in terms of what we can have before the end of the year. There will be room for us to sell out no matter who else is in the mix. And selling out is, in this case, a very good thing. Leronlimab, Sponsored by Pepsi. A drug for a new generation!

(I'd take it and it reminds me of the time that my Michigan State Spartans made a consolation bowl game that was called The Poulan Weedeater Bowl. Nothing like having "poo" in the title of your shitty bowl game.)

Oh, I wanted to talk about NASDAQ. Thankfully people have stopped obsessing over it. It will happen when it happens. I'd love for it to have happened a few weeks ago but ultimately it doesn't matter as we're still very much alive for a possible EUA or flat out approval soon. I think what occurred is that the NASDAQ folks said "you're approved but need to raise dat money since you ain't at $4".

That's how they talk, by the way. Lots of slang and poor grammar.

But now NP looks at the future and says "we'll be at (indecipherable due to audio quality) and we're very excited about the tremendous CD12 results (indecipherable due to audio) uplist after the share price rises upon the release of the interim analysis".

In other words, we could raise money right now or just wait until we get above $4 with (hopefully) the results of CD12 or other catalysts.

Well shit, you guys. I think that's all the analysis I have for right now. I dug deep. Please mash that subscribe button and like my post to get more updates straight to your box.

1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SAMILBIO Gambles on 'Chaeyun' Launch With November Events

Updated Category News Views 52

Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...

Continue Reading
CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 100

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
Can AI Help Climate? Tech Investments Seek Balance

Updated Category News Views 49

Is AI a Climate Savior or a Power-Hungry Beast? AI might feel like that unpredictable family member you hope shows up to the party with something useful, but they’ve always got high energy bills. As the tech world touts artificial intelligence as the next big hope for addressing climate woes, folks like Peter Gilmer—who's been around a few boardrooms—are taking a...

Continue Reading
Rural AI Skills Gap Uncovered: Challenges and Solutions

Updated Category News Views 137

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Continue Reading
ModelBest & OpenBMB Unveil Open-Source OCR Models

Updated Category News Views 174

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Continue Reading
Naviu's AI Travel Guide: Revolutionizing Japan Tours

Updated Category News Views 168

A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...

Continue Reading
Fluence Energy Faces Class Action: Investors Beware

Updated Category News Views 294

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Continue Reading
iTLC Traffic Systems Expand Global Reach at APTA 2026

Updated Category News Views 195

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Continue Reading
Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 248

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
XPeng Hits New Monthly Delivery Record in October

Updated Category News Views 194

XPeng Smashes Delivery Records Yet Again Ah, the green light’s on for XPeng, and it's a bright one! This October, we learned that XPeng hit the throttle hard with a new record of 50,237 vehicles delivered. Now, that's a sizable rally—a 22% climb month-over-month and shooting 20% higher than last October. For a company like XPeng, which resembles a bulldog with its...

Continue Reading

Top 5 Most Recently Viewed Articles

Bluestar Alliance Strengthens Portfolio with Dickies Acquisition

Updated Category News Views 244

Bluestar Alliance Completes Acquisition of Dickies Brand Global brand management company Bluestar Alliance has completed its acquisition of the iconic workwear and lifestyle brand Dickies from VF Corporation. This strategic move solidifies Bluestar Alliance's standing as a leader in brand management, enhancing its diverse portfolio that includes luxury, lifestyle, and...

Continue Reading
Parker-Hannifin Strengthens Position with Curtis Instruments Buy

Updated Category News Views 259

Parker-Hannifin Strengthens Position with Curtis Instruments Buy Parker-Hannifin Corporation (NYSE: PH), a leader in motion and control technologies, has officially completed its acquisition of Curtis Instruments, Inc. This significant acquisition, valued at approximately $1 billion in cash, marks a strategic move to expand capabilities within the electric and hybrid...

Continue Reading
Strategic Moves: WinVest Acquisition Corp. Reschedules Key Meeting

Updated Category News Views 156

WinVest Acquisition Corp. Adjusts Schedule for Special Meeting In an important development, WinVest Acquisition Corp. (OTC: WINV) has informed its stockholders about the rescheduling of a significant special meeting. Originally set for May, this meeting has now been moved to 11:00 a.m., Eastern Time, on May 30, 2025. It’s a move aimed at ensuring everything is in order...

Continue Reading
Headwall Investments Transforms Retail Landscape in Texas

Updated Category News Views 286

Headwall Investments Transforms Retail Landscape in Texas Headwall Investments, a Texas-based real estate firm, has taken a significant step to enhance its market presence by acquiring the Old Mill Retail Center. This marks a substantial addition to their portfolio, highlighting their commitment to dominating the convenience shopping sector across the state. Acquisition...

Continue Reading
Sophia Space's Bold Move into Space Data Centers

Updated Category News Views 11

Space: The New Frontier for Data Centers One thing's for sure—moving data centers to space isn't your run-of-the-mill tech endeavor. Sophia Space and Caltech, those hardcore space players out in Pasadena, just nailed a patent for their space-based data center idea. And let me tell ya, this is not some sci-fi fantasy. They're putting their chips on solar-powered, modular...

Continue Reading